Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ratner

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Nature Biotechnology|January 12, 2011
Pfizer reaches out to academia--againMark Ratner
Nature Biotechnology|September 2, 2004
As products enter clinic...scientists shown the doorMark Ratner
Nature Biotechnology|January 10, 2015
IL-17-targeting biologics aim to become standard of care in psoriasisMark Ratner
Nature Biotechnology|December 10, 2014
Celgene wagers on Sutro's cell-free platform to ramp up ADCsMark Ratner
Nature Biotechnology|June 10, 2016
Gilead bets big on Nimbus' fatty liver disease drugMark Ratner
Nature Biotechnology|April 10, 2010
Roche plans for more convenient-to-use Herceptin and RituxanMark Ratner
Nature Biotechnology|July 10, 2008
Dyax backs albuminMark Ratner
Nature Biotechnology|September 9, 2016
Strata rolls out drug-matching service, offers free tumor profilingMark Ratner
Nature Biotechnology|May 10, 2017
Genomics pioneer gets its first drugMark Ratner
Nature Biotechnology|July 13, 2017
FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug labelMark Ratner
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|January 12, 2011
Pfizer reaches out to academia--againMark Ratner
Nature Biotechnology|September 2, 2004
As products enter clinic...scientists shown the doorMark Ratner
Nature Biotechnology|January 10, 2015
IL-17-targeting biologics aim to become standard of care in psoriasisMark Ratner
Nature Biotechnology|December 10, 2014
Celgene wagers on Sutro's cell-free platform to ramp up ADCsMark Ratner
Nature Biotechnology|June 10, 2016
Gilead bets big on Nimbus' fatty liver disease drugMark Ratner
Nature Biotechnology|April 10, 2010
Roche plans for more convenient-to-use Herceptin and RituxanMark Ratner
Nature Biotechnology|July 10, 2008
Dyax backs albuminMark Ratner
Nature Biotechnology|September 9, 2016
Strata rolls out drug-matching service, offers free tumor profilingMark Ratner
Nature Biotechnology|May 10, 2017
Genomics pioneer gets its first drugMark Ratner
Nature Biotechnology|July 13, 2017
FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug labelMark Ratner
Pageof 11